|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,118.00 JPY | +0.10% |
|
-0.41% | +1.58% |
| Capitalization | 6,521B 42.89B 40.82B 37.83B 33.65B 60.74B 3,639B 67.31B 471B 174B 1,494B 161B 158B | P/E ratio 2025 * |
54.3x | P/E ratio 2026 * | 28.9x |
|---|---|---|---|---|---|
| Enterprise value | 10,712B 70.44B 67.05B 62.13B 55.26B 99.76B 5,978B 111B 774B 286B 2,455B 264B 259B | EV / Sales 2025 * |
2.38x | EV / Sales 2026 * | 2.31x |
| Free-Float |
-
| Yield 2025 * |
4.76% | Yield 2026 * | 4.89% |
More valuation ratios
* Estimated data
More news
Last Transcript: Takeda Pharmaceutical Company Limited
More recommendations
More press releases
More news
| 1 day | +0.10% | ||
| 1 week | -0.41% | ||
| Current month | +0.86% | ||
| 1 month | -1.77% | ||
| 3 months | -1.84% | ||
| 6 months | -2.39% | ||
| Current year | +1.58% |
1 week
4 100.00
4 178.00
1 month
4 075.004 276.00
Current year
3 852.004 494.00
1 year
3 852.004 494.00
3 years
3 075.004 873.00
5 years
2 894.504 873.00
10 years
2 894.506 693.00
| Director | Title | Age | Since |
|---|---|---|---|
Christophe Weber
CEO | Chief Executive Officer | 58 | 2015-03-31 |
Mwana Lugogo
CMP | Compliance Officer | 54 | 2011-12-31 |
Gabriele Ricci
CTO | Chief Tech/Sci/R&D Officer | 46 | 2022-01-31 |
| Manager | Title | Age | Since |
|---|---|---|---|
Christophe Weber
BRD | Director/Board Member | 58 | 2014-05-31 |
Andrew Plump
BRD | Director/Board Member | 59 | 2015-05-31 |
| Director/Board Member | 72 | 2016-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 24.44% | 16 M€ | +8.92% | ||
| 5.00% | 3,057 M€ | +24.56% | ||
| 3.80% | 1,738 M€ | +17.64% | ||
| 3.43% | 247 M€ | +20.10% | ||
| 3.26% | 66 M€ | +23.17% |
| Change | 5d. change | 1-year change | 3-years change | Capi. ($) | ||
|---|---|---|---|---|---|---|
| +0.10% | -0.41% | +0.19% | +33.66% | 42.89B | ||
| -0.50% | -1.69% | +33.70% | +227.51% | 720B | ||
| -0.56% | -0.29% | +16.21% | +104.09% | 488B | ||
| -0.25% | -2.05% | -3.36% | -9.83% | 359B | ||
| -0.51% | -3.21% | +17.68% | +40.01% | 310B | ||
| -2.69% | -0.83% | -2.65% | +39.08% | 255B | ||
| +0.53% | +0.35% | +0.12% | -32.16% | 231B | ||
| -0.37% | -0.19% | +3.61% | +26.82% | 208B | ||
| -0.49% | -2.11% | +3.06% | +18.33% | 201B | ||
| -0.68% | -0.92% | +2.46% | +30.76% | 148B | ||
| Average | -0.31% | -1.68% | +7.10% | +47.83% | 296.41B | |
| Weighted average by Cap. | -0.31% | -1.61% | +12.66% | +81.40% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 4,501B 29.6B 28.17B 26.11B 23.22B 41.92B 2,512B 46.46B 325B 120B 1,031B 111B 109B | 4,530B 29.79B 28.35B 26.28B 23.37B 42.19B 2,528B 46.76B 327B 121B 1,038B 112B 109B |
| Net income | 117B 772M 734M 681M 605M 1.09B 65.47B 1.21B 8.47B 3.13B 26.88B 2.9B 2.83B | 213B 1.4B 1.33B 1.23B 1.1B 1.98B 119B 2.2B 15.37B 5.67B 48.75B 5.25B 5.14B |
| Net Debt | 4,190B 27.56B 26.23B 24.31B 21.62B 39.03B 2,338B 43.25B 303B 112B 960B 103B 101B | 3,943B 25.93B 24.68B 22.87B 20.34B 36.72B 2,201B 40.7B 285B 105B 904B 97.35B 95.25B |
More financial data
* Estimated data
Employees
49,281
Sector
Pharmaceuticals
Calendar
2024-12-12
- R&D Day
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-12-11 | 4,118.00 ¥ | +0.10% | 2,889,400 |
| 24-12-10 | 4,114.00 ¥ | -0.29% | 3,026,400 |
| 24-12-09 | 4,126.00 ¥ | +0.07% | 2,605,400 |
| 24-12-06 | 4,123.00 ¥ | -0.36% | 2,937,400 |
| 24-12-05 | 4,138.00 ¥ | +0.07% | 2,615,600 |
Delayed Quote Japan Exchange, December 11, 2024 at 01:30 am EST
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
4,114.00JPY
Average target price
4,759.71JPY
Spread / Average Target
+15.70%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- 4502 Stock